DSC Cell Therapy – Treatment for Androgenetic Alopecia

Home/Hair Loss Articles/DSC Cell Therapy – Treatment for Androgenetic Alopecia

DSC Cell Therapy – Treatment for Androgenetic Alopecia

RCH-01 Development Status

RCH-01 is an autologous cell therapy utilizing dermal sheath cup (DSC) cells isolated from the hair follicle to treat androgenetic alopecia.  RepliCel’s proposed Phase 2 trial will enroll 160 male subjects in good health with mild to moderate androgenetic alopecia.  Dermal sheath cup cells will be isolated from a small punch biopsy taken from the back of the subject’s scalp.

These cells will be replicated and then reintroduced into balding areas on the subjects scalp.  After injections are performed subjects will return to the clinic for assessment of total, terminal and vellus hair density and cumulative hair thickness, as well safety.  Participants will remain in the trial for approximately 39 months.

Read More on Repicel

By |October 7th, 2016|Hair Loss Articles|Comments Off on DSC Cell Therapy – Treatment for Androgenetic Alopecia

About the Author:

At Medical Hair Restoration, our team of highly specialised doctors has considerable expertise in the field of helping people through medical hair restoration. As the only clinic in South Africa that treats hair loss exclusively, we’re able to focus on the most successful methods of combating balding and shedding. In order to stay at the forefront of our speciality, we keep up to date with the latest international techniques. With visits to overseas congresses, and participation in local conferences, our physicians constantly strive to bring you the most effective treatments.